Stock Track | Acadia Healthcare Soars 5.85% Intraday on Analyst Upgrades and Price Target Hikes

Stock Track
May 04

Acadia Healthcare's stock soared 5.85% during intraday trading on Monday, following a series of positive analyst actions.

Raymond James upgraded Acadia Healthcare to Strong Buy from Outperform and raised its price target to $39 from $25, representing a significant increase. Additionally, RBC Capital raised its price target on the stock to $31 from $28 while maintaining an Outperform rating. Guggenheim also maintained a Buy rating on the company.

These analyst upgrades and price target increases reflect growing optimism about Acadia Healthcare's prospects, driving investor confidence and buying activity in the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10